Wells Fargo Starts Kezer Life Sciences (KZR) at Overweight

December 7, 2021 4:39 PM EST
Get Alerts KZR Hot Sheet
Price: $7.07 --0%

Rating Summary:
    6 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 9 | Down: 30 | New: 24
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wells Fargo analyst Chris M. Carey initiates coverage on Kezer Life Sciences (NASDAQ: KZR) with a Overweight rating and a price target of $19.00.

For an analyst ratings summary and ratings history on Kezer Life Sciences click here. For more ratings news on Kezer Life Sciences click here.

Shares of Kezer Life Sciences closed at $13.44 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Wells Fargo